))
Updesh Dosanjh on Reimagining Drug Safety: Why AI Is No Longer Optional
Manage episode 484149329 series 3647866
A tartalmat a David Fung and David Samwel, David Fung, and David Samwel biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a David Fung and David Samwel, David Fung, and David Samwel vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.
In this episode of the AI Trailblazers Podcast, we’re joined by Updesh Dosanjh, Global Lead for Pharmacovigilance Technology Solutions at IQVIA, to explore how artificial intelligence is transforming drug safety at a global scale.
Updesh shares why traditional pharmacovigilance (PV) methods simply can’t keep up with today’s data volume—and how generative AI, automation, and platform thinking are helping PV teams shift from reactive to proactive safety management.
🔍 What you’ll learn in this episode:
✅ Why AI is no longer optional in pharmacovigilance
✅ How GenAI is streamlining signal detection and case processing
✅ Why scaling PV isn’t about hiring more—it’s about thinking differently
✅ The biggest mistake teams make when starting their AI journey
✅ Why platforms (not point solutions) are the future of safety innovation
Whether you're in drug safety, regulatory affairs, or digital transformation, this conversation is packed with real-world insights and bold thinking from one of the industry's leaders.
11 epizódok
Megosztás
